Duration of Postoperative Analgesia with Intravenous Nalbuphine versus Intravenous Butorphanol in Patients Undergoing Short Surgical Procedures under TIVA
Sanjot Ninave, Sudhir Ninave, P. Shiras, Neeta Chaudhari, Aruna Chandak, Vijay Chandak
Journal of Pharmaceutical Research International · pp. 46–53 · Published 27 Jan 2022
10.9734/jpri/2022/v34i5B34677Abstract
Aims and Objectives: To compare the duration of post operative analgesia of nalbuphine 0.3 mg/kg IV and butorphanol 0.04 mg/kg IV in patients posted for short surgical procedures under TIVA. Also to observe the sedation score as well as the side effects like nausea, emesis, pruritis, hypotension, respiratory depression. Materials and Methods: By closed envelope technique, sixty female patients of ASA Class I and II aged 20-60 years, who were posted for short gynaecological surgeries under TIVA were randomly allocated into two groups: Group N (nalbuphine) and Group B (butorphanol). Just prior to surgery, Group N patients got IV Nalbuphine 0.3 mg/kg, while Group B patients received IV Butorphanol 0.04 mg/kg. Patients were asked to rate their pain intensity on a VAS scale in the course of the postoperative period, and the duration of postoperative analgesia was compared between the two groups. The Modified Ramsay sedation scale was exercised to assess sedation at the time of pain complaint, and patients were additionally monitored for 24 hours post the surgery for any adverse or side effects. Results: In group N, 63.33% of patients had duration of pain relief ranging 31-50 minutes, with mean duration of analgesia being 46.333 ± 2.061. In group B, 60% of patients had duration of pain relief ranging from 11-30 minutes, with mean duration being 19.167± 1.68 minutes. In group N, 63.33% of patients had score for sedation as 3 and rest (36.67%) had a score for sedation as 2. In group B, 80% of patients had a score for sedation as 2 and rest (20%) had a score for sedation as 1. Conclusion: When compared to IV Butorphanol, intravenous Nalbuphine delivers a more effective post-operative analgesia with better sedation. IV Nalbuphine is recommended for post operative analgesia in patients undergoing short surgical procedures. Both the drugs did not cause any side effects.
Cited by 0
No indexed citations yet.
Related research
- A Prospective Randomised Controlled Study Comparing the Efficacy of Hyperbaric Levo Bupivacaine with Nalbuphine Versus Hyperbaric Ropivacaine with Nalbuphine in Subarachnoid Block for Lower Limb Orthopaedic Surgeries — shares topic coverage
- Pharmacological Features, Therapeutic Efficacy and Side Effects of Nalbuphine: A Review — shares topic coverage
- A Comparative Perspective Study between Intrathecal Midazolam & Nalbuphine as an adjuvant with Hyperbaric Bupivacaine for Post-Operative Analgesia in Total Abdominal Hysterectomy — shares topic coverage
- Management of Hypotension Post Subarachnoid Block in C Section Patients: What‘s the Difference between Ephedrine Vs Phenylephrine? — shares topic coverage
- Effect of Heroin Use on Liver Enzymes — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.